product summary
request information :
company name :
LifeSpan Biosciences
product type :
antibody
product name :
Anti-C11orf30 / EMSY Antibody (C-Terminus, clone Y474) LS-C49575
catalog :
LS-C49575
clonality :
monoclonal
host :
rabbit
reactivity :
human
application :
flow cytometry, immunocytochemistry, immunoprecipitation, western blot
more info or order :
LifeSpan Biosciences product webpage
product information
?AntibodyID :
49812
AntibodyName :
LS-C49575
TargetSpecies :
Human
Host Species :
Rabbit
Product Name :
Anti-C11orf30 / EMSY Antibody (C-Terminus, clone Y474) LS-C49575
ClonalityDesc :
Monoclonal
CloneName :
Y474
AntigenModification :
C-Terminus
PresentationDesc :
Tris-Glycine-NaCl or PBS, pH 7.2-7.4, 40-50% Glycerol, 0.01% sodium azide, 0.05% BSA
ImmunogenType :
Synthetic peptide
ImmunogenDesc :
A synthetic peptide corresponding to residues near the C-term of human EMSY isoform 1 was used as immunogen.
PurificationDesc :
Tissue culture supernatant
RecommendedStorageDesc :
Long term: -20°C; Short term: -20°C
IsotypeName :
IgG
Gene :
C11orf30 / EMSY
StandardGeneSymbol :
C11orf30
Reactivity :
Human, Mouse, Rat
Usage :
Flo (1:50), ICC (1:250 - 1:500), IP (1:50), WB (1:2000)
Synonyms :
C11orf30, EMSY, Protein EMSY, GL002
more info or order :
LifeSpan Biosciences product webpage
company information
LifeSpan Biosciences
2401 Fourth Avenue, Suite 900
Seattle, WA 98121
antibodies@lsbio.com
www.lsbio.com
1-206-464-1554
headquarters: USA
Since 1995, LifeSpan has been the industry leader in molecular pathology, specializing in the localization of proteins in normal and diseased tissues, both human and non-human. We offer more than 74,000 antibodies, custom designed immunohistochemistry (IHC) studies, immediately available human tissue IHC profiles for more than 500 proteins, and histology and pathology services. Our bank of 2 million specimens is available to support our customers' contract research studies and contains frozen and formalin-fixed (FFPE) normal and diseased tissues. Our contract services are comprehensive; they include study design, antibody sourcing and characterization, tissue sourcing and validation, immunolabeling, trouble shooting, and interpretation of the results by a LifeSpan pathologist.